临床心血管病杂志
臨床心血管病雜誌
림상심혈관병잡지
JOURNAL OF CLINICAL CARDIOLOGY
2001年
5期
211-213
,共3页
戴研%于全俊%贾云香%孙继良%张树星
戴研%于全俊%賈雲香%孫繼良%張樹星
대연%우전준%가운향%손계량%장수성
脂蛋白类%绝经%冠状动脉疾病
脂蛋白類%絕經%冠狀動脈疾病
지단백류%절경%관상동맥질병
目的:研究脂蛋白(a)[Lp(a)]与绝经后女性冠心病(CHD)的关系,并初步探讨内源性雌激素对血清Lp(a)水平的影响。方法:采用ELISA法测定52例绝经后女性CHD患者及48例健康者的血清Lp(a)浓度,并测定了其中40例CHD患者和30例健康者的雌激素水平。结果:CHD组平均Lp(a)浓度显著高于对照组[(252.9±31.5)∶(129.2±20.0)mg/L,P<0.01],且与冠状动脉病变支数相关,r=0.398,P<0.001;而血清Lp(a)浓度与雌二醇水平未见显著关联。结论:血清Lp(a)水平的增加是CHD的独立危险因子,也是冠状动脉病变严重程度的一个预测因素,其浓度与内源性雌激素水平无关。
目的:研究脂蛋白(a)[Lp(a)]與絕經後女性冠心病(CHD)的關繫,併初步探討內源性雌激素對血清Lp(a)水平的影響。方法:採用ELISA法測定52例絕經後女性CHD患者及48例健康者的血清Lp(a)濃度,併測定瞭其中40例CHD患者和30例健康者的雌激素水平。結果:CHD組平均Lp(a)濃度顯著高于對照組[(252.9±31.5)∶(129.2±20.0)mg/L,P<0.01],且與冠狀動脈病變支數相關,r=0.398,P<0.001;而血清Lp(a)濃度與雌二醇水平未見顯著關聯。結論:血清Lp(a)水平的增加是CHD的獨立危險因子,也是冠狀動脈病變嚴重程度的一箇預測因素,其濃度與內源性雌激素水平無關。
목적:연구지단백(a)[Lp(a)]여절경후녀성관심병(CHD)적관계,병초보탐토내원성자격소대혈청Lp(a)수평적영향。방법:채용ELISA법측정52례절경후녀성CHD환자급48례건강자적혈청Lp(a)농도,병측정료기중40례CHD환자화30례건강자적자격소수평。결과:CHD조평균Lp(a)농도현저고우대조조[(252.9±31.5)∶(129.2±20.0)mg/L,P<0.01],차여관상동맥병변지수상관,r=0.398,P<0.001;이혈청Lp(a)농도여자이순수평미견현저관련。결론:혈청Lp(a)수평적증가시CHD적독립위험인자,야시관상동맥병변엄중정도적일개예측인소,기농도여내원성자격소수평무관。
Objective:To evaluate the correlation between the Lp(a)concentration and coronary heart disease (CHD) in postmenopausal women, and to approach the effects of endogenous estrogen level on the serum Lp(a). Method:Serum Lp(a) concentrations were measured in 100 postmenopausal women with or without CHD by ELISA. Serum estradiol (E2) level was determined in 70 women. Result:Women suffered from CHD had significant higher Lp(a) concentrations than controls [(252.9±31.5)vs(129.2±20.0)mg/L, P<0.01]. Logistic regression analysis showed that the serum Lp(a) concentration was significantly correlated with CHD, and increase in serum Lp(a) was an independent risk factor (the adjusted OR is 4.54, P<0.01). Serum Lp(a) values had a grade association with the severity of CHD (the spearman rank correlation coefficient is 0.398, P<0.001). Whereas the serum E2 had no correlation with Lp(a) concentration. Conclusion:Our result indicates that elevated Lp(a) is an independent risk factor for CHD in postmenopausal women, and is a predictor for the severity of CHD. The serum Lp(a) concentration does not correlated with the endogenous estrogen level.